<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>0001.txt
<DESCRIPTION>CURRENT REPORT
<TEXT>



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934



                                 Date of report:
                                January 30, 2001
                        Date of earliest event reported:
                                January 30, 2001



                                   PFIZER INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)



            Delaware                    001-03619              13-5315170
--------------------------------------------------------------------------------
  (State or other jurisdiction       (Commission File       (I.R.S. Employer
       of incorporation)                 Number)           Identification No.)



        235 East 42nd Street, New York, New York                  10017
--------------------------------------------------------------------------------
        (Address of principal executive offices)                (Zip Code)



               Registrant's telephone number, including area code
                                 (212) 573-2323



--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

<PAGE>


Item 5.     Other Events.

On January 30, 2001, Pfizer Inc. entered into an indenture with The Chase
Manhattan Bank. The indenture is included as Exhibit 4 and is incorporated by
reference into the Registration Statement on Form S-3 (Registration No.
333-48382) as an exhibit to such Registration Statement.



Item 7(c).  Exhibits.

4    Indenture, dated as of January 30, 2001, between Pfizer Inc. and The Chase
     Manhattan Bank.


<PAGE>


                                    SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant
has caused this report to be signed on its behalf by the authorized undersigned.



                                   PFIZER INC.
                                   --------------------------------------------
                                   (Registrant)



Date:  January 30, 2001            /s/ Margaret M. Foran
                                   --------------------------------------------
                                   Name: Margaret M. Foran
                                   Title: Vice President - Corporate Governance


<PAGE>


                                  EXHIBIT INDEX


Exhibit 4  -  Indenture, dated as of January 30, 2001, between Pfizer Inc. and
              The Chase Manhattan Bank.


</TEXT>
</DOCUMENT>